HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Dmitriy M Niyazov Selected Research

Glycogen Storage Disease Type II (Pompe's Disease)

1/2019An immune tolerance approach using transient low-dose methotrexate in the ERT-naïve setting of patients treated with a therapeutic protein: experience in infantile-onset Pompe disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Dmitriy M Niyazov Research Topics

Disease

2Mitochondrial Diseases (Mitochondrial Disease)
10/2018 - 07/2016
1Congenital Heart Defects (Congenital Heart Defect)
01/2021
1Glycogen Storage Disease Type II (Pompe's Disease)
01/2019
1Chromosome Aberrations (Chromosome Abnormalities)
10/2018
1Microcephaly
06/2011
1Type II Microcephalic Osteodysplastic Primordial Dwarfism
06/2011
1Heart Failure
03/2011
1Kearns-Sayre Syndrome
03/2011
1Orofaciodigital syndrome 6
09/2008

Drug/Important Bio-Agent (IBA)

2Proteins (Proteins, Gene)FDA Link
01/2019 - 07/2016
2Mitochondrial DNA (mtDNA)IBA
10/2018 - 07/2016
2Biomarkers (Surrogate Marker)IBA
10/2018 - 07/2016
1phospholipase D1IBA
01/2021
1GlucosidasesIBA
01/2019
1human GAA protein (Myozyme)FDA Link
01/2019
1AcidsIBA
01/2019
1Methotrexate (Mexate)FDA LinkGeneric
01/2019
1DNA (Deoxyribonucleic Acid)IBA
07/2016
1Centrosomal Associated ProteinsIBA
06/2011
1LY 165163 (PAPP)IBA
09/2008

Therapy/Procedure

1Heart Transplantation (Grafting, Heart)
03/2011